The Potential Role of Glycogen Synthase Kinase 3 Inhibitors as Amyotrophic Lateral Sclerosis Pharmacological Therapy

By  

Current Medicinal Chemistry, Vol. 18, Iss. 20, 2011-07 ,pp. : 3028-3034

Bentham Science Publishers

Access to resources Recommend Favorite

Vertex inhibitors of Aurora-2, glycogen synthase kinase-3 and Src kinase

By  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 3, 2004-03 ,pp. : 439-443

Informa Healthcare

Access to resources Recommend Favorite

Glycogen Synthase Kinase-3 (GSK-3) Inhibitors for the Treatment of Alzheimer's Disease

By  

Current Pharmaceutical Design, Vol. 16, Iss. 25, 2010-08 ,pp. : 2790-2798

Bentham Science Publishers

Access to resources Recommend Favorite

Design of Glycogen Synthase Kinase-3 Inhibitors: An Overview on Recent Advancements

By  

Current Pharmaceutical Design, Vol. 19, Iss. 26, 2013-08 ,pp. : 4755-4775

Bentham Science Publishers

Access to resources Recommend Favorite

Glycogen Synthase Kinase 3 as an Anticancer Drug Target: Novel Experimental Findings and Trends in the Design of Inhibitors

By  

Current Pharmaceutical Design, Vol. 19, Iss. 4, 2013-02 ,pp. : 665-679

Bentham Science Publishers

Access to resources Recommend Favorite